Nanobiotix S.A.
NANO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €142,741 | €235,621 | €252,285 |
| - Cash | €28,818 | €49,737 | €66,335 | €75,283 |
| + Debt | €46,505 | €50,902 | €49,168 | €50,565 |
| Enterprise Value | – | €143,906 | €218,454 | €227,567 |
| Revenue | €26,638 | -€20,898 | €9,289 | €32,915 |
| % Growth | 227.5% | -325% | -71.8% | – |
| Gross Profit | €26,638 | -€20,898 | €9,289 | €32,915 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | €1,091 | -€44,422 | -€23,244 | -€4,942 |
| % Margin | 4.1% | 212.6% | -250.2% | -15% |
| Net Income | -€5,383 | -€46,260 | -€21,872 | -€11,601 |
| % Margin | -20.2% | 221.4% | -235.5% | -35.2% |
| EPS Diluted | -0.11 | -0.98 | -0.46 | -0.3 |
| % Growth | 88.8% | -113% | -53.3% | – |
| Operating Cash Flow | -€17,411 | -€13,715 | -€5,836 | €4,799 |
| Capital Expenditures | -€150 | -€357 | -€489 | -€5 |
| Free Cash Flow | -€17,561 | -€14,074 | -€6,325 | €4,794 |